| Email This Article Email This Article  | 

Biotech firm set to rise: TFN Hot Stock Pick of the Week Video

Posted May 22, 2008

Laura Cadden on TFN Hot Stock Pick of the Week

Baltimore — (TFN): The development of cutting-edge biologic drugs that are already improving – even saving – lives marks Osiris Therapeutics as a winner among biotech stocks. Their multi-purpose wonder-drug Prochymal is set to be the first FDA approved stem cell therapy.

Watch the Today’s Financial News video.

****Make sure you sign up for our FREE TFN News Feed for breaking news, special reports and new financial videos. Click here to pick your favorite reader. If you prefer to have the feed delivered to your email, just click here. 


Related Articles


Comments

close Reblog this comment
blog comments powered by Disqus